State of Wyoming’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52,339
Closed -$492K 1948
2026
Q1
$492K Buy
+52,339
New +$469K 0.06% 323
2025
Q4
Sell
-41,212
Closed -$585K 1841
2025
Q3
$585K Buy
+41,212
New +$544K 0.07% 240
2025
Q1
Sell
-51,019
Closed -$927K 1668
2024
Q4
$927K Buy
51,019
+24,227
+90% +$326K 0.12% 90
2024
Q3
$360K Buy
26,792
+16,612
+163% +$245K 0.05% 331
2024
Q2
$141K Sell
10,180
-1,204
-11% -$19.1K 0.02% 815
2024
Q1
$213K Buy
11,384
+1,093
+11% +$21.9K 0.04% 559
2023
Q4
$233K Buy
10,291
+5,706
+124% +$124K 0.04% 468
2023
Q3
$114K Buy
4,585
+132
+3% +$3.32K 0.02% 779
2023
Q2
$125K Sell
4,453
-1,015
-19% -$25.2K 0.04% 681
2023
Q1
$122K Buy
5,468
+344
+7% +$9.01K 0.04% 646
2022
Q4
$136K Buy
5,124
+115
+2% +$3.75K 0.05% 573
2022
Q3
$142K Buy
5,009
+403
+9% +$10.4K 0.07% 383
2022
Q2
$96K Buy
4,606
+1,853
+67% +$34.7K 0.06% 523
2022
Q1
$60K Sell
2,753
-1,025
-27% -$22.2K 0.03% 947
2021
Q4
$105K Buy
+3,778
New +$91.6K 0.05% 586

Other funds holding CCRN

State of Wyoming's CCRN Position: Q2 2026 in Review

State of Wyoming sold out of Cross Country Healthcare (CCRN) in Q2 2026, closing a stake of 52,339 shares — an estimated $492K sold.

State of Wyoming first reported a position in CCRN in Q4 2021 and held it in 15 quarters. The position peaked at $927K in Q4 2024. 42 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • State of Wyoming reported no remaining Cross Country Healthcare position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 52,339 Cross Country Healthcare shares in Q2 2026, an estimated $492K.
  • State of Wyoming first reported a position in Cross Country Healthcare in Q4 2021 and held it in 15 quarters.
  • State of Wyoming's Cross Country Healthcare position peaked at $927K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.